ZA201204294B - Therapeutic combinations of theobromine and an antihistamine - Google Patents

Therapeutic combinations of theobromine and an antihistamine

Info

Publication number
ZA201204294B
ZA201204294B ZA2012/04294A ZA201204294A ZA201204294B ZA 201204294 B ZA201204294 B ZA 201204294B ZA 2012/04294 A ZA2012/04294 A ZA 2012/04294A ZA 201204294 A ZA201204294 A ZA 201204294A ZA 201204294 B ZA201204294 B ZA 201204294B
Authority
ZA
South Africa
Prior art keywords
theobromine
antihistamine
therapeutic combinations
therapeutic
combinations
Prior art date
Application number
ZA2012/04294A
Inventor
John Brew
Robin Mark Bannister
Original Assignee
Biocopea Lilmited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocopea Lilmited filed Critical Biocopea Lilmited
Publication of ZA201204294B publication Critical patent/ZA201204294B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ZA2012/04294A 2009-12-14 2012-06-12 Therapeutic combinations of theobromine and an antihistamine ZA201204294B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0921803.3A GB0921803D0 (en) 2009-12-14 2009-12-14 Drug composition and its use in therapy
PCT/GB2010/052086 WO2011073647A1 (en) 2009-12-14 2010-12-14 Therapeutic combinations of theobromine and an antihistamine

Publications (1)

Publication Number Publication Date
ZA201204294B true ZA201204294B (en) 2013-02-27

Family

ID=41667043

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2012/04294A ZA201204294B (en) 2009-12-14 2012-06-12 Therapeutic combinations of theobromine and an antihistamine

Country Status (17)

Country Link
EP (1) EP2512472A1 (en)
JP (2) JP2013513652A (en)
CN (1) CN102802625A (en)
AU (1) AU2010332495C1 (en)
BR (1) BR112012014159A8 (en)
CA (1) CA2784215A1 (en)
CO (1) CO6541638A2 (en)
GB (1) GB0921803D0 (en)
IL (1) IL220384A0 (en)
MX (1) MX2012006624A (en)
NZ (1) NZ600267A (en)
PE (1) PE20121538A1 (en)
RU (1) RU2012129675A (en)
SG (2) SG10201408374WA (en)
UA (1) UA105827C2 (en)
WO (1) WO2011073647A1 (en)
ZA (1) ZA201204294B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
CN103263533B (en) * 2013-05-31 2014-11-05 杨宏伟 Theobromine composition for treating cough and application and preparation thereof
CN104188998A (en) * 2014-09-18 2014-12-10 中山大学 Naringin and fexofenadine hydrochloride drug composition and preparation thereof
CN104224819B (en) * 2014-09-18 2016-08-17 中山大学 A kind of naringin and levo-cetirizine hydrochloride pharmaceutical composition and preparation thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE59550T1 (en) * 1986-04-17 1991-01-15 Alza Corp CHLORPHENIRAMINE THERAPY.
HUP9700654A2 (en) 1997-03-26 1999-09-28 Dezső Korbonits Antitussive compositions containing theobromine
JPH10316568A (en) * 1997-05-13 1998-12-02 Taisho Pharmaceut Co Ltd Pharmaceutical composition
JP2003012514A (en) * 2001-07-02 2003-01-15 Taisho Pharmaceut Co Ltd Medicament composition
JP2003128549A (en) * 2001-08-15 2003-05-08 Rohto Pharmaceut Co Ltd Composition applicable to mucous membrane
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
RU2009141592A (en) * 2007-04-11 2011-05-20 Алькон Рисерч, Лтд. (Us) USE OF TNFα INHIBITOR IN COMBINATION WITH ANTIHISTAMINE TREATMENT FOR TREATMENT OF ALLERGIC RHINITIS AND ALLERGIC CONJUNCTIVITIS

Also Published As

Publication number Publication date
AU2010332495C1 (en) 2016-02-11
AU2010332495B2 (en) 2015-01-22
NZ600267A (en) 2013-07-26
BR112012014159A2 (en) 2017-08-29
PE20121538A1 (en) 2012-12-21
WO2011073647A1 (en) 2011-06-23
JP2013513652A (en) 2013-04-22
JP6078605B2 (en) 2017-02-08
MX2012006624A (en) 2012-10-05
CA2784215A1 (en) 2011-06-23
RU2012129675A (en) 2014-01-27
EP2512472A1 (en) 2012-10-24
SG181603A1 (en) 2012-07-30
SG10201408374WA (en) 2015-01-29
CN102802625A (en) 2012-11-28
CO6541638A2 (en) 2012-10-16
JP2016040280A (en) 2016-03-24
GB0921803D0 (en) 2010-01-27
AU2010332495A1 (en) 2012-06-21
IL220384A0 (en) 2012-08-30
BR112012014159A8 (en) 2017-12-26
UA105827C2 (en) 2014-06-25

Similar Documents

Publication Publication Date Title
HK1173654A1 (en) Therapeutic compounds and related methods of use
IL215251A0 (en) Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
IL220384A0 (en) Therapeutic combinations of theobromine and an antihistamine
EP2477634A4 (en) Non-sedating antihistamine injection formulations and methods of use thereof
HK1217903A1 (en) Methods of administering pirfenidone therapy
IL218316A0 (en) Combination therapy with nanoparicle compositions of taxane and hedgehog inhibitors
EP2448581A4 (en) Therapeutic compositions and related methods of use
IL236830A0 (en) Diazahomoadamantane derivatives and methods of use thereof
EP2429566A4 (en) Cyclin dependent kinase inhibitors and methods of use
SG10201405568UA (en) 4-substituted pyridin-3-yl-carboxamide compounds and methods of use
EP2411024A4 (en) Factor viii variants and methods of use
IL218212A0 (en) Therapeutic methods and compositions
HRP20130538T1 (en) Therapeutic uses of quinazolinedione derivatives
EP2393787A4 (en) Cadherin-11 inhibitors and methods of use thereof
ZA201201287B (en) Therapeutic aryl-amido-aryl compounds and their use
GB201211237D0 (en) CDK5 inhibitors and therapeutic uses thereof
PL2442811T3 (en) Theobromine for the treatment of cough
EP2461870A4 (en) Therapeutic compositions and methods
GB0809936D0 (en) Therapeutic use of zolpidem
GB0819854D0 (en) Therapeutic use of zolpidem
HK1174620A1 (en) Indazolyl-substituted dihydroisoxa-zolopyridines and methods of use thereof
GB0913300D0 (en) Therapeutic compounds and their use
TWM369662U (en) Improvement of portable ashtray
GB0903651D0 (en) Inhibitors of glyoxalase